NYSE · Specialty Chemicals · USD
Ashland Inc. (ASH) Stock Analysis
Ashland Inc. (ASH) is a Specialty Chemicals stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ASH Key Statistics
As of Sep 4, 2026Trading
- Open
- $72.53
- Previous Close
- $73.20
- Day's Range
- 71.00–73.71
- 52-Week Range
- 46.30–78.25
- Volume
- 398.10K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.39
Valuation
- Market Cap
- $3.34B
- P/E Ratio
- 47.05
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 16.96
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.23
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.81
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.55
Financials (FY)
- Revenue (FY)
- $1.82B−13.68%
- Net Income (FY)
- −$845.00M−600.00%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.82%
- Shares Outstanding
- 45.79M
- 1-Year Return
- +37.43%
Dividend and dates
- Dividend
- $1.68+2.30%
- Ex-Dividend Date
- September 1, 2026
- Earnings Date
- November 3, 2026estimated
- Avg Volume
- 870.24K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
ASH Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +26.05% |
| 2025 | −15.40% |
| 2024 | −13.71% |
| 2023 | −20.24% |
| 2022 | +1.14% |
| 2021 | +37.67% |
| 2020 | +5.05% |
| 2019 | +9.42% |
| 2018 | +0.90% |
| 2017 | +34.95% |
| 2016 (partial year) | −3.65% |
As of September 4, 2026.
ASH Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.82B | −$845.00M | −46.3% |
| 2024 | $2.11B | $169.00M | 8.0% |
| 2023 | $2.19B | $178.00M | 8.1% |
| 2022 | $2.39B | $927.00M | 38.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.82B | $549.00M | $88.00M | −$845.00M | −46.3% |
| 2024 | $2.11B | $618.00M | $83.00M | $169.00M | 8.0% |
| 2023 | $2.19B | $668.00M | $159.00M | $178.00M | 8.1% |
| 2022 | $2.39B | $830.00M | $288.00M | $927.00M | 38.8% |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
ASH Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.26 | 3 | — |
| 2025 | $1.65 | 4 | +3.1% |
| 2024 | $1.60 | 4 | +7.4% |
| 2023 | $1.49 | 4 | +14.2% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.26 | 3 | — |
| 2025 | $1.65 | 4 | +3.1% |
| 2024 | $1.60 | 4 | +7.4% |
| 2023 | $1.49 | 4 | +14.2% |
| 2022 | $1.31 | 4 | +11.1% |
| 2021 | $1.18 | 4 | +6.8% |
| 2020 | $1.10 | 4 | +2.3% |
| 2019 | $1.08 | 4 | +10.3% |
| 2018 | $0.98 | 4 | +12.6% |
| 2017 | $0.87 | 4 | +353.8% |
| 2016 | $0.19 | 1 | — |
Most recent payment: $0.42 per share, ex-dividend September 1, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
ASH Valuation vs Specialty Chemicals Median
Median of 71 stocks| Metric | ASH | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/E | 47.05 | 28.71 | 64% above |
| P/S ratio | 1.81 | 1.68 | 8% above |
| Profit margin | 2.82% | 0.08% | 2.7 pts above |
Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Ashland to host Innovation Day for analysts and investors
YahooAshland (ASH) Up 2% Since Last Earnings Report: Can It Continue?
YahooASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth
YahooAshland Launches permexa Sodium Caprate To Advance Oral Delivery Of Peptides, Biologics, And GLP‑1 Therapies
BenzingaAshland Inc.: Activist Pressure Starts To Pay Off
SeekingAlphaAshland board authorizes quarterly dividend
Yahoo
All 18 articles ↓Show fewer ↑
Ashland Is Said To Explore Sale After Getting Takeover Interest
BenzingaMorgan Stanley Maintains Equal-Weight on Ashland, Raises Price Target to $78
BenzingaAshland Inc. 2026 Q3 - Results - Earnings Call Presentation
SeekingAlphaWells Fargo Maintains Equal-Weight on Ashland, Raises Price Target to $70
BenzingaUBS Maintains Buy on Ashland, Raises Price Target to $83
BenzingaEvercore ISI Group Maintains In-Line on Ashland, Raises Price Target to $73
BenzingaAshland (ASH) Could Be 19% Undervalued After Mixed Quarter And Lower EPS View
YahooAshland Inc. (ASH) Q3 2026 Earnings Call Transcript
SeekingAlphaAshland Inc (ASH) Q3 2026 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ...
YahooAshland Q3 Earnings Call Highlights
YahooAshland Inc. Q3 2026 Earnings Call Summary
YahooAshland's Q3 Earnings Miss Estimates, Sales Beat on Volume Growth
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Specialty Chemicals Stocks
Linde plc
$220.15B
SHWThe Sherwin-Williams Company
$81.01B
ECLEcolab Inc.
$78.29B
APDAir Products and Chemicals, Inc.
$67.09B
PPGPPG Industries, Inc.
$25.02B
IFFInternational Flavors & Fragrances Inc.
$22.03B
Popular Basic Materials Stocks
BHP Group Limited
$229.80B
RIORio Tinto Group
$167.95B
SCCOSouthern Copper Corporation
$167.82B
NEMNewmont Corporation
$134.97B
FCXFreeport-McMoRan Inc.
$104.44B











